89.36
2.30 (2.64%)
| Previous Close | 87.06 |
| Open | 87.34 |
| Volume | 1,131,188 |
| Avg. Volume (3M) | 1,759,852 |
| Market Cap | 12,068,715,520 |
| Price / Earnings (TTM) | 28.92 |
| Price / Earnings (Forward) | 21.74 |
| Price / Sales | 4.40 |
| Price / Book | 2.69 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | 7.39% |
| Operating Margin (TTM) | 16.43% |
| Diluted EPS (TTM) | 1.34 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Quarterly Earnings Growth (YOY) | 76.30% |
| Total Debt/Equity (MRQ) | 2.27% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 645.55 M |
| Levered Free Cash Flow (TTM) | 636.51 M |
| Return on Assets (TTM) | 5.84% |
| Return on Equity (TTM) | 4.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Globus Medical, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.38 |
|
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 100.63% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 114.00 (Barclays, 27.57%) | Buy |
| Median | 100.00 (11.91%) | |
| Low | 64.00 (Stifel, -28.38%) | Hold |
| Average | 93.89 (5.07%) | |
| Total | 7 Buy, 2 Hold | |
| Avg. Price @ Call | 82.72 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 17 Dec 2025 | 105.00 (17.50%) | Buy | 85.06 |
| Freedom Capital Markets | 17 Dec 2025 | 87.00 (-2.64%) | Hold | 85.06 |
| RBC Capital | 17 Dec 2025 | 100.00 (11.91%) | Buy | 85.06 |
| 07 Nov 2025 | 92.00 (2.95%) | Buy | 83.89 | |
| Morgan Stanley | 02 Dec 2025 | 100.00 (11.91%) | Buy | 89.03 |
| Truist Securities | 18 Nov 2025 | 105.00 (17.50%) | Buy | 83.42 |
| 07 Nov 2025 | 93.00 (4.07%) | Buy | 83.89 | |
| Barclays | 10 Nov 2025 | 114.00 (27.57%) | Buy | 86.36 |
| B of A Securities | 07 Nov 2025 | 91.00 (1.84%) | Buy | 83.89 |
| Wells Fargo | 07 Nov 2025 | 79.00 (-11.59%) | Buy | 83.89 |
| Stifel | 28 Oct 2025 | 64.00 (-28.38%) | Hold | 62.75 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Nov 2025 | Announcement | Globus Medical Reports Third Quarter 2025 Results |
| 16 Oct 2025 | Announcement | Globus Medical Schedules Third Quarter Earnings Release and Conference Call |
| 14 Oct 2025 | Announcement | Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |